XML 55 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Asset purchase by Century Therapeutics Canada ULC (Details) - In-process research and development (IPR&D) asset - Empirica Agreement - USD ($)
$ in Thousands
1 Months Ended
Jun. 09, 2020
Feb. 28, 2023
Jun. 30, 2022
Jul. 31, 2021
Mar. 31, 2023
Dec. 31, 2022
Asset Acquisition [Line Items]            
Total consideration transferred $ 4,519          
Buyer transaction expenses 203          
Escrow deposit $ 1,506          
Release of escrow deposit   $ 494 $ 517 $ 523    
Accrued expenses and other liabilities            
Asset Acquisition [Line Items]            
Accrued compensation expense         $ 0 $ 220